Methods

Preparation of Heat Shock Protein Inhibitor-loaded Silica-coated Fe 3 O 4 Nanoparticles (HSPI&Fe 3 O 4 @SiNPs)
Firstly, the Fe 3 O 4 NPs were synthesized according to the literature procedure [1] .
Briefly, an aqueous solution of FeCl 3 (2 mL, 1 mol/L) and FeCl 2 (0.5 mL, 2 mol/L, Sigma-Aldrich) in 2 mol/L HCl was mixed and added into diluted NH 3 solution (25 mL, 0.7 mol/L) and stirred for 30 min. Then, the precipitate was isolated by magnetic decantation and centrifugation. Solutions of Heat Shock Protein Inhibitor (HSPI, Selleckchem) were prepared by dissolving in PSB. Silica coating on the Fe 3 O 4 NPs was accomplished by a water-in-oil reverse micelle method [2] . Typically, 350 μL Fe 3 O 4 nanoparticles (2.0 mg/mL) and 50 μg/mL HSPI were dispersed into 7.7 mL cyclohexane, 2 mL Triton X-100, and 1.6 mL hexanol and stirred for 30 min to generate the microemulsion system. Then, 40 µL tetraethoxy orthosilicate (TEOS) was added to the mixture, followed by the addition of 100 µL aqueous ammonia for the TEOS hydrolysis under stirring for 24 h. After that, 50 µL tetraethoxy orthosilicate (TEOS) and 50 µL 3-aminopropyl triethoxysilane (APTS)/50 µL carboxyethylsilane triol sodium salt (CETS) were added to the mixture for another 24 h stirring. Finally, acetone was added to destabilize the microemulsion system. The HSPI-loaded Fe 3 O 4 @SiNPs were isolated via centrifugation and washed in sequence with ethanol and D.I. water for purification. All the reagents were obtained from Sigma-Aldrich.
Conjugation of Specific Antibody with HSPI-loaded Fe 3 O 4 @SiNPs
For specific antibody conjugation, the carboxyl functional groups were activated by The heat generation capabilities of the MNPs were measured using a 5 cm diameter 8-turn induction coil powered by a 3 kW alternating magnetic field (AMF) generator (SPG-06A, Shenzhen Shuangping Power Supply Technologies Co. Ltd.). Four differentiation samples (PBS, SiNPs, Fe 3 O 4 @SiNPs, and CD20-Fe 3 O 4 @SiNPs) were exposed to the AMF for 30 min. The frequency was kept constant at 350 kHz and the 21 kA/m field strength, and the temperature was monitored by using a thermometer immersed in a test tube containing 1 mg/ml of NPs solution.
In vitro Anti-cancer Drug Loading and Release
For HSPI loading, 50 μg/mL HSPI were dispersed into the reaction solution. UV-vis spectrophotometer (PerkinElmer, PE Lamda 750, USA) in the range of 200-800 nm was used to calculate the loading amount of HSPI at 350 nm by the subtraction of free HSPI in the washing solution from the original amount. The encapsulation efficiency (EE) was calculated by using the following formula:
The loading efficiency (LE) was evaluated by using the following formula:
For drug release, 1 mL medium dispersed-HSPI-loaded Fe 3 O 4 @SiNPs was placed in a dialysis bag (weight cut-off of 10 kDa), and then immersed in 9 mL PBS and kept in an AMF at a constant temperature. Samples (300 mL) were periodically collected and the same volume of fresh medium was added. The amount of released HSPI was analyzed via UV-Visible spectrophotometry (U-3900, Hitachi) and the concentration-absorbance standard equation.
Lung Cancer Stem Cell Culture
Human lung cancer stem cell line (LCSC) originated from human small cell lung cancer tissue was purchased from Celprogen (Cat# 36107-34, Celprogen, USA). Cell culture completed medium, 0.05% Trypsin-EDTA, and culture plates were purchased from Celprogen. Antibiotic solution (penicillin and streptomycin) were purchased from Invitrogen. LCSCs were maintained in a serum-free medium (DMEM/F12) supplemented with 2% B27, 10 ng/ml bFGF and EGF, 1% N2, and 1% antibiotic solution and cultured in a humidified atmosphere containing 5% CO 2 at 37 o C. The differentiated LCSCs (dLCSCs) were obtained by culturing LCSCs in the completed medium with 10% fetal bovine serum (FBS). The fresh medium was replaced ever three days of culture.
Immunofluorescence Staining for Stemness Analysis of LCSCs
The stemness of LCSCs was examined by immunofluorescence staining of surface makers and stemness markers. Briefly, LCSCs were cultured in 24-well plates were fixed with a solution of 4% paraformaldehyde in PBS for 30 min at 4°C, washed in PBS, treated with PBS/5% BSA for 1 h at room temperature and then stained with primary antibodies (Invitrogen) at room temperature for 1 h. The primary antibodies used were anti-human CD20 PE conjugated, anti-human CD15 FITC conjugated, anti-human ABCG APC conjugated. For analysis of stemness marker Oct4 expression, cells were fixed in 4% paraformaldehyde/PBS for 10 min, permeabilized with 0.1% Triton X-100 in PBS for 5 min, blocked with 3% BSA/PBS for 30 min, and then incubated with anti-human Oct4 FITC conjugated (Invitrogen) at room temperature for 1 h. The nuclei were stained with DAPI. Cells were then washed as described above and observed under the Laser-scanning confocal microscope (Leica SPE).
Tumor Sphere Formation Assay
LCSCs (3 rd and 10 th generation) were plated at a density of 10,000 cells/well in 6-well nonadherent plates (Corning Inc.) in DMEM/F12 cell medium, supplemented with human EGF (10 ng/mL, Invitrogen), N2 (1% v/v, Invitrogen), and human bFGF (10 ng/mL, Invitrogen). Fresh aliquots of EGF and bFGF were added every other day, and the spheres were collected at day 12 following gravity-based sedimentation and/or low-speed centrifugation to remove any remaining single cells. Spheres were then washed once with PBS, followed by gentle resuspension in cell detachment solution and constant trituration for at least 20 min to obtain single cells. The dissociated single cells of the primary spheres were washed at least three times with the medium and then plated for sequential sphere-formation for an additional 12 days.
In vitro Cytotoxicity of Multifunctional Nanoparticles
To study the cytotoxicity of designed nanoparticles, LCSCs were seeded at 5×10 3 cells/well in a 96-well plate, pre-incubated for 24 h, then incubated with 
Hemolysis Assay and Biochemical Analysis
The whole blood was centrifuged at 3000 rpm for 5 min to harvest the red blood cells 
Tumor Xenograft and Organ Tissues Staining
To further investigate the therapeutic effects of MNPs on tumor-bearing mice treated by retro-orbital sinus injection, the tumors were excised for immunohistochemisical (IHC) analysis on day 40 post-injection. Meanwhile, organs were collected for studying the side effects of MNPs on mice by IHC analysis. After fixation, tissues were sectioned at 5 µm thickness after fixing in formalin and embedding in paraffin, and then stained with hematoxylin and eosin (H&E). The IHC images were taken under a microscope (CX41, Olympus). The significant treatment efficiency of MNPs was evaluated by immunofluorescence staining. Tumor xenograft sections were incubated with anti-CD20/PE to at 37 °C for 1 h, and then examined by a confocal microscope. Figure S1 . A lung cancer stem cell model with specific expression of CD20, CD15, ABCG2, and a stemness marker Oct4 (blue color: nucleus). 
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